Biomolecular Engineering Overview

Principles

Definition

Biomolecular engineering is a multidisciplinary field that integrates principles from chemical engineering, molecular biology, biochemistry, and other life sciences to understand, manipulate, and design biological systems and processes at the molecular level. It focuses on creating novel products, devices, and technologies by leveraging the functions and interactions of biomolecules to address challenges in areas such as human health, environmental sustainability, and bio-based manufacturing.

Ontological type

Key Applications

Core Methods

Design Principles

Key developments

Key Figures

Quantitative Enzymology Foundations era

Eugene P. Kennedy[1] emerged as a leading figure in the Quantitative Enzymology Foundations era, with institutional ties including University of California, Berkeley[3] and the University of Chicago[4]. His key contribution—the function of cytidine coenzymes in the biosynthesis of phospholipides[7]—helped anchor coenzyme-centric mechanistic axes and turn lipid biosynthesis into a quantitative design problem. Arthur Kornberg[2] conducted work across the Weizmann Institute of Science[5] and Washington University in St. Louis[6], reflecting the era's cross-institutional mobility. Kornberg's enzymatic investigations—enzymatic synthesis of the CoA derivatives of long-chain fatty acids[8], the enzymatic mechanism of oxidation-reductions between malate or isocitrate and pyruvate[9], and nucleotide pyrophosphatase[10]—advanced understanding of energy and phosphate transfer, driving reproducible purification and quantitative kinetic frameworks that defined early biomolecular engineering.

Standardized Molecular Toolchains era

Tom Maniatis [1] operated across Harvard University [3] and Stanford University [4] during the Standardized Molecular Toolchains era. His key contribution in this era was the Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter [7], a development that anchored RNA tooling and probe generation within standardized workflows. W. W. Cleland [2] is associated with the University of Wisconsin–Madison [5] and University of Chicago [6] during this era. His contributions comprise the 1963 papers The kinetics of enzyme-catalyzed reactions with two or more substrates or products☆I. Nomenclature and rate equations [8], The kinetics of enzyme-catalyzed reactions with two or more substrates or products [9], and The kinetics of enzyme-catalyzed reactions with two or more substrates or products☆II. Inhibition: Nomenclature and theory [10], which established standardized kinetic frameworks essential for biochemical engineering and experimental design in this era.

Programmable Biointerfaces era

Helen M. Berman [1] is a central figure in this era, with affiliations at the Institute of Cancer Research [3] and Stanford University [4]. Her key contribution is the Protein Data Bank [6], which unified macromolecular structure data and enabled rapid, large-scale collaboration essential for computation-driven design in programmable biointerfaces. A. Paul Alivisatos [2] has held roles at the University of California, San Francisco [5] and Stanford University [4] during this era. His groundbreaking work on Semiconductor Nanocrystals as Fluorescent Biological Labels [7], Shape control of CdSe nanocrystals [8], and Organization of 'nanocrystal molecules' using DNA [9] helped realize programmable nano-bio interfaces by enabling tunable optical reporters and DNA-directed assembly that underpin high-throughput design and targeted theranostics.